Abstract
Purpose: To explore the efficacy and safety of the third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Osimertinib ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
